Page last updated: 2024-12-11
armillarisin a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5320192 |
MeSH ID | M0080686 |
Synonyms (25)
Synonym |
---|
armillarisin a |
3-acetyl-5-hydroxymethyl-7-hydroxycoumarin |
2h-1-benzopyran-2-one, 3-acetyl-7-hydroxy-5-(hydroxymethyl)- |
3-acetyl-7-hydroxy-5-(hydroxymethyl)-2h-1-benzopyran-2-one |
AKOS005766028 |
FT-0652980 |
3-acetyl-7-hydroxy-5-(hydroxymethyl)chromen-2-one |
53696-74-5 |
3-acetyl-5-hydroxylmethyl-7-hydroxycoumarin |
A829738 |
3-acetyl-7-hydroxy-5-(hydroxymethyl)-1-benzopyran-2-one |
3-ethanoyl-5-(hydroxymethyl)-7-oxidanyl-chromen-2-one |
unii-m5864mh5ct |
m5864mh5ct , |
armillarisin a [who-dd] |
3-acetyl-7-hydroxy-5-(hydroxymethyl)-2h-chromen-2-one |
DTXSID40201953 |
AC-8248 |
armillarisinuma |
HY-108013 |
BCP13473 |
Q10883374 |
A13228 |
CS-0027150 |
MS-23349 |
Research Excerpts
Pharmacokinetics
Excerpt | Reference | Relevance |
---|---|---|
" This assay has been successfully applied to a pharmacokinetic and tissue distribution study after intravenous injection of ASE in mouse in a dose of 10 mg/kg." | ( Preclinical pharmacokinetic analysis of armillarisin succinate ester in mouse plasma and tissues by LC-MS/MS. Chen, Q; Li, P; Zhang, J; Zhu, J, 2013) | 0.39 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (14)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (21.43) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 19.72
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.72) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (6.25%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 15 (93.75%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |